BillionToOne, Inc. (BLLN) income statement
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$91.54−5.96 (-6.11%)
Close on Nov 18, 2026Market cap $4.32BP/E –Yield –
BillionToOne, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 71.4%
- Operating margin
- 10.2%
- Net margin
- 11.3%
- Return on equity, FY2025
- 6.5%
Financial strength
- Current ratio
- 11.25
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 926.0%
Valuation
- P/E ratio
- –
- Price to sales
- 9.89
- Price to book
- 7.62
- Dividend yield
- –
See a number that looks wrong?